Mashrav builds precision document translation software for global enterprises. Faithful layout. Protected terminology. Audit-ready output. Built natively on AWS.
DocXlate translates complex PDF documents while preserving their exact visual layout. Tables stay tables. Footnotes stay footnotes. Your brand stays your brand.
Every translated region is fitted back into the original bounding box. Multi-candidate rendering with adaptive font scaling means the document looks right, not just translated.
Domain glossaries shield product names, drug INNs, regulatory abbreviations, and financial terms from mistranslation. Zero glossary misses on protected terms.
Automatically detects pages with image-embedded text and routes them through OCR supplementation before translation. Scanned documents are not second-class.
Every job produces a structured review.json with region-level warnings, overflow flags, glossary hits, and a manual review requirement signal.
Each domain pack adds industry-specific glossaries, layout profiles, quality gates, and post-processing rules. Generic translation tools don't know what an INN is. DocXlate does.
Annual reports, earnings releases, ESG filings, prospectuses, and investor presentations. Handles complex financial tables, footnotes, and GAAP/non-GAAP reconciliations.
Clinical study reports, investigator brochures, drug package inserts, pharmacovigilance reports, and regulatory submissions for FDA, EMA, PMDA, and ANVISA.
Contracts, arbitration documents, court filings, cross-border agreements, and compliance documentation. Preserves clause structure, defined terms, and section numbering.
Safety data sheets (SDS/MSDS), technical manuals, product certifications, and multilingual compliance documentation for global manufacturing operations.
Proprietary documents never leave your AWS environment. DocXlate deploys into your VPC via AWS PrivateLink. No public internet egress required for enterprise tier.
Lambda, S3, DynamoDB, and Amazon Translate form a zero-idle-cost architecture. Pay only for documents processed. Scales from one document a week to thousands per day.
Deploy in any AWS region to meet data residency requirements. EU customers can keep documents in eu-west-1. APAC customers in ap-southeast-1. Your data stays where it must.
Every translation decision is logged — which regions were translated, which overflowed, which glossary terms fired. Tamper-evident output for regulated industries.
Amazon Bedrock Data Automation integration for complex hybrid pages and image-embedded text. Foundation model extraction where traditional OCR falls short.
Metered billing through AWS Marketplace. Usage tracked per page, per document, or by monthly volume tier. No separate invoicing relationship required.
DocXlate is listed on AWS Marketplace. Billing goes directly through your existing AWS account — no new vendor relationship, no purchase order, no separate invoicing.
Document translation with layout preservation
Marketplace listing coming Q2 2026
Mashrav LLC is an AWS-native software company building precision document intelligence tools for organizations that operate across borders and languages.
Our first product, DocXlate, was built to solve a problem we kept seeing: organizations that need faithful, production-quality translations of complex formatted documents — annual reports, regulatory submissions, technical manuals — and have no reliable tool that preserves layout, protects terminology, and produces audit-ready output.
We are headquartered in the United States and operate exclusively on AWS infrastructure. Our customers' documents are processed within their own AWS environment.
We optimize for translation accuracy and layout fidelity, not raw throughput. A document that looks wrong costs more to fix than it saved to produce.
Every domain gets its own pack — glossaries, quality gates, layout profiles, compliance requirements. Generic translation is not our market.
Audit trails, VPC deployment, and data residency are first-class features, not enterprise add-ons. We build for the compliance requirements of pharma and finance from day one.
Whether you're processing public financial reports or proprietary pharmaceutical submissions, we'd like to hear what you're working with.